erythromycin has been researched along with Community Acquired Infection in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 31 (29.52) | 18.2507 |
2000's | 56 (53.33) | 29.6817 |
2010's | 15 (14.29) | 24.3611 |
2020's | 3 (2.86) | 2.80 |
Authors | Studies |
---|---|
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
Chiba, N; Hasegawa, K; Iwata, S; Matsubara, K; Morozumi, M; Nakayama, E; Sunakawa, K; Takayanagi, R; Ubukata, K | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
Blackman Northwood, J; Coley, MD; Cossins, LR; Creti, R; Del Grosso, M; Farrell, DJ; Pantosti, A | 1 |
Alharbi, L; Alkhamisi, R; Alradadi, R; Ashy, N; Eljaaly, K | 1 |
Aljabri, A; Almehmadi, M; Alqahtani, N; Alraddadi, B; Aseeri, MA; Assabban, Z; Bahobail, F; Botaish, A; Eljaaly, K; Hashim, A; Thabit, AK; Torres, A | 1 |
Han, Z; Lin, J; Wang, Y; Yao, Z; Zhou, J | 1 |
Huang, CY; Huang, YC; Wang, HK | 1 |
Gao, W; Liu, D; Ma, Y; Peng, H | 1 |
Debata, NK; Dubey, D; Padhy, RN; Rath, S; Rout, S; Sahu, MC | 1 |
Cao, B; Gao, Y; Han, GJ; Liu, YM; Liu, YN; Qu, JX; Wang, H; Wang, RT; Yin, YD | 1 |
Chang, AB; Gardiner, SJ; Gavranich, JB | 1 |
Changchien, CH; Chen, SW; Chen, YY; Chu, C | 1 |
Gostev, VV; Higuchi, W; Hung, WC; Iwao, Y; Khokhlova, OE; Peryanova, OV; Reva, GV; Reva, IV; Salmina, AB; Sidorenko, SV; Singur, OA; Teng, LJ; Wan, TW; Yamamoto, T | 1 |
Arija, V; Bejarano-Romero, F; Cliville-Guasch, X; de Diego, C; Gomez-Bertomeu, F; Ochoa-Gondar, O; Raga-Luria, X; Salsench, E; Vila-Corcoles, A | 1 |
Armstrong, JR; Fritz, SA; Gaudreault, M; Hunstad, DA; Loughman, JA; Mardis, ER; Mitchell, K; Orscheln, RC; Sellenriek, PL; Storch, EK; Storch, GA | 1 |
Brown, NM; Carmichael, AJ; Cooke, FJ; Ganner, M; Gkrania-Klotsas, E; Howard, JC; Kearns, AM; Stone, M | 1 |
Bernardin, G; Cua, E; de Salvador, F; Dellamonica, J; Hyvernat, H; Landraud, L; Risso, K; Roger, PM; Vassallo, M | 1 |
Kawai, Y; Miyashita, N; Oka, M; Ouchi, K; Yamaguchi, T | 1 |
Kawai, Y; Kobayashi, H; Kobayashi, T; Maruyama, T; Miyashita, N; Oka, M; Ouchi, K; Taguchi, O; Yamaguchi, T | 1 |
Bianco, O; Crivellaro, S; Leone, I; Savoia, D | 1 |
Ashley, EA; Lubell, Y; Turner, P; White, NJ | 1 |
Alikhani, MY; Moez, HJ; Sedighi, I | 1 |
Chang, AB; Gavranich, JB; Gillies, MB; Mulholland, S | 1 |
Forrest, A; Gudgel, LD; Niederman, MS; Paladino, JA | 1 |
Castro-Rodriguez, JA; Girardi, G; Kogan, R; Martínez, MA; Payá, E; Puppo, H; Quevedo, I; Rubilar, L | 1 |
Felmingham, D; Hoban, D; Waites, K | 1 |
Aoshima, M; Chonabayashi, N; Satoh, T; Uchiyama, N | 1 |
Angulo, GB; Castanheira, M; Felmingham, D; López, H; Marin, ME; Mendes, C; Mimica, I; Quiñones, F; Rossi, F; Segura, AJ; Sifuentes-Osornio, J; Siller, CC; Starling, C; Súcari, A; Zoccoli, CM | 1 |
Badaró, R; Bumroongkit, C; Corrêa, JC; Dolmann, AL; Juárez Martínez, LG; Mayrinck, LR; Mera, JR; Tamez, R; Yang, JY | 1 |
Martynova, AV; Turcutyuicov, VB | 1 |
Brown, SD; Farrell, DJ; Morrissey, I | 1 |
Amsden, GW | 1 |
Guchev, IA; Ivanitsa, GV; Klochkov, OI; Pervov, IuA; Rosman, SV; Shturmina, SM | 1 |
Bonofiglio, L; de Mier, C; Famiglietti, A; Gutkind, G; Mollerach, M; Ojeda, MI; Vay, C | 1 |
Asche, C; Halpern, MT; Lavin, B; Mandell, LA; Nieman, R; Sarocco, PW; Schmier, JK; Snyder, LM | 1 |
García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH | 1 |
Dworkin, MS | 1 |
Granizo Martínez, JJ | 1 |
Arnold, FW; Wojda, B | 1 |
Brown, SD; Farrell, DJ; Jenkins, SG; Klugman, KP; Lavin, BS; Patel, M | 1 |
Dunbar, L; Fogarty, C; Kohno, S; Nusrat, R; Rangaraju, M; van Rensburg, DJ | 1 |
Lee, WK; Young, BW | 1 |
De Salvo, MC; Fogarty, C; Nusrat, R; Rangaraju, M; van Rensburg, D | 1 |
Bauer, TT; Petermann, W; Reimnitz, P; Schürmann, D; Welte, T | 1 |
Fuller, JD; Low, DE; McGeer, A | 1 |
Cappuccinelli, P; Ceccarelli, D; Colombo, MM; Folgosa, E; Mondlane, J; Sale, M; Salvia, AM | 1 |
Allan, RC; Melzer, M; Moghal, M; Wijesuriya, V | 1 |
Beach, JA; DeFine, LA; DiPersio, JR; DiPersio, LP | 1 |
Cohen, CR; Holmes, KK; Karimi, F; Kariuki, JN; Kigo, A; Meier, AS; Muyodi, JA; Mwachari, CW; Nduba, VN; Park, DR | 1 |
Cohen, SH; Flynn, NM; Huang, H; King, JH; Monchaud, C; Morita, M | 1 |
Alonso, E; Brouwer, WP; Delgado, E; Hak, E; Hoepelman, IM; Matute, AJ | 1 |
Blasi, F; de Caprariis, PJ; Feldman, C; Garbino, J; Hoepelman, IM; Hogan, P; Tamm, M; Todisco, T | 1 |
Guss, J; Kazahaya, K | 1 |
Adelman, MH; Iannini, PB; Paladino, JA; Schentag, JJ | 1 |
Appelbaum, PC; Aydin, N; Bogdanovich, T; Bozdogan, B; Chavez-Bueno, S; McCracken, G | 1 |
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
Cantón, R; Farrell, DJ; Unal, S | 1 |
Chen, JM; Huang, LM; Lee, CY; Lee, PI; Wu, MH | 1 |
Blussé van Oud Alblas, A; Boekhout, M; Bohte, R; Hermans, J; Lobatto, S; Nauta, EH; van den Broek, PJ; van't Wout, JW | 1 |
Beale, AS; Masson, ND | 1 |
Melikhov, OG; Strachunskiĭ, LS; Sudilovskaia, NN | 1 |
García-Oñive, E; Iglesias, R; Iñíguez, R; Narváez, A; Sánchez, F; Sánchez, JF | 1 |
Bru, JP; Gaillat, J; Sedallian, A | 1 |
Kanavaki, S; Karabela, S; Legakis, NJ; Marinis, E | 1 |
White, RJ | 1 |
Brückner, OJ; Liippo, K; Puolijoki, H; Rodrig, J; Smits, JP; Tala, E | 1 |
Fisher, D; Moore, J; Towns, ML | 1 |
Garau, J; Grassi, C; Hosie, J; Huchon, G; Legakis, N; Lode, H; Segev, S; Wijnands, G | 1 |
Aubier, M; Gialdroni-Grassi, G; Hosie, J; Huchon, G; Legakis, N; Lode, H; Regamey, C; Segev, S; Tolstuchow, N; Vester, R; Wijnands, WJ | 1 |
Baños, V; Canteras, M; Gómez, J; Muñoz, L; Nuñez, ML; Ruiz Gómez, J; Soto, MC; Valdés, M | 1 |
Kane, GC | 1 |
Gossens, MM; Kimpen, JL; Roord, JJ; Wolf, BH | 1 |
Jamil, B; Minai, AM; Mouton, SW; Sampers, GH; Smits, AJ; Sturm, AW; van der Pol, R; van Hellemondt, FM | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
Coley, CM; Fine, MJ; Gleason, PP; Kapoor, WN; Lave, JR; Marrie, TJ; Obrosky, DS; Schulz, R; Singer, DE; Stone, RA | 1 |
Berk, SL | 1 |
Swartz, MN | 1 |
Bock, HL; Bogaerts, H; Kiederle, S; Laukamp, S; Postels-Multani, S; Schmitt, HJ; Wirsing von König, CH | 1 |
Butt, CJ; Palmer, KT; Rampling, A; Tully, M; West, AA | 1 |
Krone, LV | 1 |
Macfarlane, JT; Tang, CM | 1 |
Woodhead, M | 1 |
Abramo, T; Ahmed, A; Carubelli, C; Leinonen, M; McCoig, C; McCracken, GH; Muniz, L; Trujillo, M; Wubbel, L | 1 |
Blumenschein, K; Howard, KB; Rapp, RP | 1 |
Cellesi, C; Cresti, S; Lattanzi, M; Montagnani, F; Oster, P; Rossolini, GM; Zanchi, A | 1 |
Marre, R; Trautmann, M | 1 |
Bradley, K; Kdesh, A; Manthous, CA; McPherson, CA; Yasick, D; Yaylali, Y | 1 |
Orrett, FA | 1 |
Goss, TF; Najib, MM; Stein, GE | 1 |
Bates, J; File, TM; Grayston, JT; Indorf, A; Phillips, J; Sarosi, GA; Summersgill, J; Tan, J; Vergis, EN; YU, VL | 1 |
Adderson, E; Carroll, K; Christenson, J; Davis, R; Leonard, R; Pavia, A | 1 |
See, S | 1 |
Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 1 |
Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M | 1 |
Castaño, E; Castrejón, MM; de Atencio, I; de Morales, I; McCracken, GH; Muñiz, L; Olsen, K; Sáez-Llorens, X; Vallarino, D; Wubbel, L | 1 |
Dunbar, L; Fogarty, CM; Greenberg, RN; Kojak, CM; Marrie, TJ; Morgan, N; Player, R; Williams, RR | 1 |
Barnes, DJ; Dobbin, CJ; Duggan, CJ | 1 |
Fukano, H; Hara, F; Hara, H; Matsushima, T; Miyashita, N; Nakajima, T; Niki, Y | 1 |
Alegre-Martin, J; Odenholt, I; Petermann, W; Phillips, MJ; Tack, K; Trostmann, U; Welling, L; Willcox, PA | 1 |
Casellas, JM; Gliosca, L; Tomé, G; Visser, M | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Schwarz, S; Verhoef, J | 1 |
8 review(s) available for erythromycin and Community Acquired Infection
Article | Year |
---|---|
Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Pneumonia; Randomized Controlled Trials as Topic | 2022 |
Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Humans; Male; Pneumonia, Bacterial | 2020 |
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Community-Acquired Infections; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic | 2015 |
Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics.
Topics: Adult; Africa South of the Sahara; Anti-Bacterial Agents; Asia; Azithromycin; Child; Clarithromycin; Community-Acquired Infections; Confounding Factors, Epidemiologic; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Klebsiella; Macrolides; Microbial Sensitivity Tests; Neisseria meningitidis; Salmonella enterica; Streptococcus agalactiae; Streptococcus pyogenes | 2011 |
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Community-Acquired Infections; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic | 2012 |
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Chronic Disease; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Inflammation; Macrolides; Respiratory Tract Infections | 2005 |
Meta-analysis of bacterial resistance to macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2005 |
Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.
Topics: Community-Acquired Infections; Disease Management; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Macrolides; Penicillin Resistance; Pneumonia, Pneumococcal; Risk Factors; Streptococcus pneumoniae; Treatment Failure | 2005 |
24 trial(s) available for erythromycin and Community Acquired Infection
Article | Year |
---|---|
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Cefuroxime; Community-Acquired Infections; Confidence Intervals; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Erythromycin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Probability; Sensitivity and Specificity | 2002 |
Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Topics: Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Humans; Infant; Male; Penicillins; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2003 |
[The efficacy of switch therapy in community-acquired pneumonia in Japan].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Critical Pathways; Erythromycin; Female; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Minocycline; Pneumonia; Prospective Studies | 2003 |
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia | 2003 |
[Efficacy and safety of azithromycin prophylaxis of respiratory tract infections in military community].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Carrier State; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Military Personnel; Nasopharyngeal Diseases; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Russia; Streptococcus pneumoniae | 2004 |
Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Erythromycin; Female; Humans; Ketolides; Male; Middle Aged; Penicillin Resistance; Pneumonia, Pneumococcal; Treatment Outcome | 2005 |
Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Treatment Outcome | 2005 |
Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Hospitalization; Humans; Injections, Intravenous; Male; Moxifloxacin; Parenteral Nutrition; Pneumonia, Bacterial; Prospective Studies; Quinolines; Remission Induction; Time Factors | 2005 |
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Random Allocation; Treatment Outcome | 2007 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Mycoplasma Infections; Pneumonia; Treatment Outcome | 2008 |
Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Community-Acquired Infections; Erythromycin; Female; Humans; Injections, Intravenous; Male; Middle Aged; Multivariate Analysis; Penicillin G; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Radiography; Treatment Outcome | 1995 |
[Rovamycin (spiramycin)--a macrolide antibiotic for intravenous administration: a trial in the treatment of pneumonia].
Topics: Acute Disease; Adolescent; Adult; Aged; Community-Acquired Infections; Erythromycin; Humans; Infusions, Intravenous; Middle Aged; Pneumonia; Spiramycin; Tablets; Time Factors | 1995 |
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Drug Tolerance; Erythromycin; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillin G; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Streptococcus pneumoniae; Treatment Outcome | 1994 |
A comparative study of dirithromycin and erythromycin in bacterial pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chlamydia Infections; Community-Acquired Infections; Double-Blind Method; Erythromycin; Female; Humans; Legionnaires' Disease; Macrolides; Male; Middle Aged; Pneumonia; Pneumonia, Mycoplasma | 1994 |
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Treatment Failure | 1995 |
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae | 1996 |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Child, Preschool; Community-Acquired Infections; Erythromycin; Follow-Up Studies; Humans; Pneumonia; Prospective Studies; Respiratory Tract Infections | 1996 |
Factors influencing the analysis of secondary prevention of pertussis.
Topics: Child, Preschool; Community-Acquired Infections; Diphtheria-Tetanus-Pertussis Vaccine; Disease Transmission, Infectious; Erythromycin; Family; Female; Germany; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Prospective Studies; Socioeconomic Factors; Whooping Cough | 1997 |
Etiology and treatment of community-acquired pneumonia in ambulatory children.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Viral; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Infant; Nasopharynx; Outpatient Clinics, Hospital; Pneumonia, Bacterial; Pneumonia, Viral; Prospective Studies | 1999 |
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia; Prospective Studies | 2000 |
[Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma | 1998 |
Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Ofloxacin; Pneumonia, Pneumococcal | 2001 |
A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2001 |
73 other study(ies) available for erythromycin and Community Acquired Infection
Article | Year |
---|---|
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S | 2008 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Global Health; Humans; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Population Surveillance; Respiratory Tract Infections; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Prevalence, risk factors, phenotypic and molecular characteristics for Staphylococcus aureus carriage in community-based drug users in Guangzhou, China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carrier State; China; Clindamycin; Community-Acquired Infections; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Drug Users; Erythromycin; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Nose; Penicillins; Phenotype; Phylogeny; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Surveys and Questionnaires | 2020 |
Clinical features and molecular characteristics of childhood community-associated methicillin-resistant Staphylococcus aureus infection in a medical center in northern Taiwan, 2012.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Female; Hospitals; Humans; Infant; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Retrospective Studies; Staphylococcal Infections; Taiwan | 2017 |
Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012-2017.
Topics: Anti-Bacterial Agents; China; Clindamycin; Community-Acquired Infections; Erythromycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Staphylococcal Infections; Tertiary Care Centers; Virulence; Virulence Factors | 2018 |
A report on infection dynamics of inducible clindamycin resistance of Staphylococcus aureus isolated from a teaching hospital in India.
Topics: Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Female; Hospitals, Teaching; Humans; India; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus | 2013 |
[Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Topics: Adult; Aged; Anti-Bacterial Agents; China; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2013 |
Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Toxins; Catheter-Related Infections; Clindamycin; Community-Acquired Infections; Cross Infection; Erythromycin; Exfoliatins; Exotoxins; Female; Genotype; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Taiwan; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Complete Circular Genome Sequence of Successful ST8/SCCmecIV Community-Associated Methicillin-Resistant Staphylococcus aureus (OC8) in Russia: One-Megabase Genomic Inversion, IS256's Spread, and Evolution of Russia ST8-IV.
Topics: Bacterial Proteins; Base Sequence; Biological Evolution; Community-Acquired Infections; DNA, Bacterial; DNA, Circular; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genome, Bacterial; Genotype; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Sequence Data; RNA, Messenger; RNA, Ribosomal, 16S; Russia; Sequence Analysis, DNA; Sequence Inversion; Virulence | 2016 |
Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blood; Cefotaxime; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oxacillin; Pneumococcal Infections; Serotyping; Spain; Sputum; Streptococcus pneumoniae | 2009 |
contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections.
Topics: Abscess; Adolescent; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Child; Child, Preschool; Clindamycin; Cluster Analysis; Community-Acquired Infections; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Female; Genotype; Humans; Leukocidins; Male; Methicillin; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus | 2009 |
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Users; Erythromycin; Fusidic Acid; Gentamicins; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Phenotype; Staphylococcal Infections; United Kingdom; Young Adult | 2010 |
[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Cohort Studies; Community-Acquired Infections; Comorbidity; Erythromycin; Female; France; Hospital Mortality; Hospitals, University; Humans; Legionella; Legionnaires' Disease; Lung Diseases, Fungal; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Rifampin; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2010 |
Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Japan; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Prevalence; RNA, Ribosomal, 23S | 2010 |
Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.
Topics: Adolescent; Adult; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Radiography; RNA, Ribosomal, 23S | 2011 |
Surveillance of methicillin-resistant Staphylococcus aureus isolated in Torino (northwest Italy).
Topics: Anti-Bacterial Agents; Bacterial Toxins; Bacterial Typing Techniques; Ciprofloxacin; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Exotoxins; Hospitals, Teaching; Humans; Interspersed Repetitive Sequences; Italy; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Sentinel Surveillance; Staphylococcal Infections; Staphylococcus Phages | 2011 |
Nasal carriage of methicillin resistant Staphylococcus aureus and their antibiotic susceptibility patterns in children attending day-care centers.
Topics: Anti-Bacterial Agents; Carrier State; Child; Child Day Care Centers; Child, Preschool; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Infant; Iran; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nose; Prevalence; Staphylococcal Infections; Sulfamethoxazole; Surveys and Questionnaires; Trimethoprim | 2011 |
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study.
Topics: Anti-Bacterial Agents; Canada; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Penicillin G; Respiratory Tract Infections; Sensitivity and Specificity; Streptococcal Infections; Streptococcus pneumoniae; United States | 2003 |
Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).
Topics: Anti-Bacterial Agents; Argentina; Brazil; Community-Acquired Infections; Drug Resistance, Multiple; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Mexico; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Population Surveillance; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2003 |
Macrolide resistance in Streptococcus pneumoniae strains collected in the Far East of Russia from 2000 to 2002.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Russia; Streptococcus pneumoniae | 2003 |
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Population Surveillance; Prevalence; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 2004 |
Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
Topics: Adult; Anti-Bacterial Agents; Argentina; Bacterial Proteins; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome | 2005 |
Adults are whooping, but are internists listening?
Topics: Adolescent; Adult; Community-Acquired Infections; Diagnosis, Differential; Disease Notification; Erythromycin; Humans; Incidence; Internal Medicine; Physician's Role; Prevalence; United States; Whooping Cough | 2005 |
[Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides].
Topics: beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Utilization; Erythromycin; Humans; Macrolides; Penicillin Resistance; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Spain; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2005 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Communicable Diseases, Emerging; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Infant; Infant, Newborn; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Pneumococcal Infections; Population Surveillance; Respiratory Tract Infections; Streptococcus pneumoniae | 2005 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
Sporadic methicillin resistance in community acquired Staphylococcus aureus in Mozambique.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Deoxyribonucleases, Type II Site-Specific; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Methicillin; Methicillin Resistance; Molecular Epidemiology; Mozambique; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline Resistance; Trimethoprim Resistance | 2005 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; Erythromycin; Humans; Male; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Students | 2006 |
Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Membrane Proteins; Methyltransferases; Streptococcus pneumoniae; United States | 2006 |
Clinical presentation among HIV-infected and non-infected adults with community acquired pneumonia in Nairobi.
Topics: Adult; Anti-Bacterial Agents; Chi-Square Distribution; Community-Acquired Infections; Erythromycin; Female; HIV Infections; Humans; Kenya; Male; Pneumonia; Prognosis; Proportional Hazards Models; Risk Factors; Surveys and Questionnaires; Treatment Outcome | 2006 |
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; California; Clindamycin; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous | 2006 |
Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Chlamydophila pneumoniae; Community-Acquired Infections; Cross-Sectional Studies; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoplasma pneumoniae; Nicaragua; Oxacillin; Penicillins; Pneumonia, Bacterial; Prevalence; Pseudomonas aeruginosa; Sputum; Staphylococcus aureus; Streptococcus pneumoniae | 2006 |
Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Infant; Lymphadenitis; Male; Methicillin Resistance; Neck; Oxacillin; Penicillin Resistance; Pharyngeal Diseases; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Erythromycin; Female; Hospital Costs; Hospitalization; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies | 2007 |
Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Child, Preschool; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Exotoxins; Humans; Leukocidins; Methicillin Resistance; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Texas | 2007 |
Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Population Surveillance; Respiratory Tract Infections; Streptococcus pneumoniae | 2007 |
Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chlamydophila pneumoniae; Community-Acquired Infections; Doxycycline; Erythromycin; Humans; Lactams; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections | 1994 |
[Penicillin and erythromycin resistance in community-acquired pneumococcal pneumonia].
Topics: Aged; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pneumonia, Pneumococcal; Retrospective Studies | 1994 |
Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in Greece.
Topics: Chloramphenicol; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Greece; Humans; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Tetracycline Resistance | 1994 |
Why use erythromycin?
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Digestive System; Drug Administration Schedule; Erythromycin; Humans; Practice Patterns, Physicians'; Respiratory Tract Infections; Sexually Transmitted Diseases | 1994 |
Community-acquired pneumonia due to Legionella gormanii.
Topics: Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Legionella; Legionellosis; Male; Middle Aged; Rifampin | 1994 |
Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Penicillin Resistance; Pneumonia, Bacterial; Prognosis; Prospective Studies; Streptococcus pneumoniae | 1996 |
Legionella species community-acquired pneumonia.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Erythromycin; Humans; Legionnaires' Disease | 1997 |
Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ampicillin; Anti-Infective Agents; Community-Acquired Infections; Data Collection; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Middle Aged; Nonprescription Drugs; Pakistan; Respiratory Tract Infections; Self Medication | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Community-Acquired Infections; Comorbidity; Erythromycin; Female; Humans; Immunocompetence; Logistic Models; Male; Middle Aged; Outcome Assessment, Health Care; Outpatients; Pneumonia; Practice Guidelines as Topic; Societies, Medical; Statistics, Nonparametric | 1997 |
Therapy for severe community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Guidelines as Topic; Humans; Penicillins; Pneumonia, Bacterial | 1997 |
Use of antimicrobial agents and drug resistance.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Microbial; Drug Utilization; Erythromycin; Humans; Streptococcus pyogenes | 1997 |
Community-acquired Legionnaires' disease following minimal exposure to a contaminated source.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Fluorescent Antibody Technique, Indirect; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Rifampin; Water Microbiology; Water Supply | 1997 |
The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease.
Topics: Adult; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Legionnaires' Disease; Male | 1998 |
Early management of younger adults dying of community acquired pneumonia.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Carbon Dioxide; Catchment Area, Health; Chronic Disease; Community-Acquired Infections; Critical Care; England; Erythromycin; Female; Floxacillin; Humans; Male; Middle Aged; Oxygen; Patient Admission; Penicillins; Pneumonia; Referral and Consultation; Retrospective Studies | 1993 |
Community acquired pneumonia in elderly people. Addition of erythromycin is not currently justified.
Topics: Aged; Anti-Bacterial Agents; Chlamydia Infections; Community-Acquired Infections; Erythromycin; Humans; Pneumonia, Bacterial; Practice Guidelines as Topic | 1998 |
Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Erythromycin; Humans; Male; Medical Records; Middle Aged; Pneumonia; Retrospective Studies | 1999 |
Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Humans; Italy; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1999 |
[Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Germany; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Population Surveillance; Respiratory Tract Infections; Sampling Studies; Streptococcus pneumoniae; Tetracycline | 1999 |
Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Erythromycin; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Torsades de Pointes | 1999 |
Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Topics: Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Trinidad and Tobago; Vancomycin | 1999 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
A community pseudo-outbreak of invasive Staphylococcus aureus infection.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Disease Outbreaks; DNA, Bacterial; Erythromycin; Gentamicins; Humans; Male; Methicillin Resistance; Nafcillin; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance | 2000 |
The efficacy of an antibiotic protocol for community-acquired pneumonia.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Clinical Protocols; Community-Acquired Infections; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Erythromycin; Female; Hospital Mortality; Humans; Injections, Intravenous; Male; Middle Aged; New South Wales; Penicillin G; Penicillins; Pneumonia; Prognosis; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2001 |
[A case of Coxiella burnetii pneumonia in an adult].
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Coxiella burnetii; Erythromycin; Humans; Indonesia; Japan; Male; Middle Aged; Pneumonia, Bacterial; Q Fever; Travel; Zoonoses | 2001 |
In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2002 |
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus | 2002 |